(E)-7-[2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid
Names
[ CAS No. ]:
81443-73-4
[ Name ]:
(E)-7-[2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid
Chemical & Physical Properties
[ Density]:
1.21g/cm3
[ Boiling Point ]:
657.5ºC at 760 mmHg
[ Molecular Formula ]:
C29H35NO5
[ Molecular Weight ]:
477.59200
[ Flash Point ]:
351.4ºC
[ Exact Mass ]:
477.25200
[ PSA ]:
76.07000
[ LogP ]:
4.66770
[ Index of Refraction ]:
1.603
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- MJ9651150
- CHEMICAL NAME :
- 4-Heptenoic acid, 7-(5-((1,1'-biphenyl)-4-ylmethoxy)-2-(4-morpholinyl)- 3-oxocyclopentyl)-, (1-alpha(Z),2-beta,5-alpha)-(+-)-
- CAS REGISTRY NUMBER :
- 81443-73-4
- LAST UPDATED :
- 199706
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C29-H35-N-O5
- MOLECULAR WEIGHT :
- 477.65
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 750 mg/kg
- SEX/DURATION :
- female 12-16 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - body wall
- REFERENCE :
- ParMM# Personal Communication from M.M. Parkinson, Glaxo Group Research Limited, Ware, Hertfordshire, SG12 0DJ, UK, Mar. 24, 1987 Volume(issue)/page/year: 24MAR1987
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1500 mg/kg
- SEX/DURATION :
- female 12-16 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- REFERENCE :
- TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 39,537,1989
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.